Schedule 13D ownership disclosure

Jade Biosciences Inc

Common Stock, par value $0.0001 per share · CUSIP: 008064206

Event date: 2025-04-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sofinnova Venture Partners X, L.P. ("SVP X")Reported CIK 0001680200

    Shares: 107,391.00 · Class: 0.3%

  • Sofinnova Management X, L.P. ("SM X LP")

    Shares: 107,391.00 · Class: 0.3%

  • Sofinnova Management X-A, L.L.C. ("SM X LLC")

    Shares: 107,391.00 · Class: 0.3%

  • Dr. James I. Healy ("Healy")

    Shares: 107,391.00 · Class: 0.3%

  • Dr. Maha Katabi ("Katabi")

    Shares: 107,391.00 · Class: 0.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-023732
Form type
SCHEDULE 13D/A
Filer
Jade Biosciences, Inc.
CIK
CIK 1798749
Filed
Mar 05, 2026
Reporting period
Apr 28, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub